NHMRC produces impact case studies to demonstrate its contribution to raising the standard of individual and public health throughout Australia.
Each case study is developed in partnership with one or more Australian research organisations and other bodies.
These case studies demonstrate that outcomes and impact can take many years, and the combined work of many people and organisations, to generate. Through documenting research translation journeys they show that the creation of knowledge is vital, but also that there are many other activities necessary to generate impact.
NHMRC impact case studies
|Picato gel||QIMR Berghofer||16 December 2018|
|Aridol and Bronchitol||The University of Sydney||16 December 2018|
|The TRIUMPH study||The George Institute for Global Health||28 March 2019|
|Pharmaxis||Pharmaxis Ltd||8 April 2019|
|SMARThealth||The George Institute for Global Health||18 July 2019|
|Neurodegenerative disease and metals||The Florey Institute of Neuroscience and Mental Health||27 November 2019|
|Severe Asthma: Mepolizumab||Hunter Medical Research Institute (HMRI)||28 November 2019|
|Fetal Alcohol Spectrum Disorder||The Telethon Kids Institute and The Sydney University||25 February 2020|
If you have any comments or suggestions, would like to be kept informed when new case studies are published, or would like to discuss partnering with NHMRC to document your organisation’s work as an NHMRC case study, then please let us know.
You can contact the Impact Case Studies team at firstname.lastname@example.org.
- These impact Case Studies are not intended to be used as a template to guide the development of case studies for inclusion within NHMRC grant applications. Please follow the instructions within the relevant Grant Guidelines when applying for an NHMRC grant.
- NHMRC does not endorse or recommend any commercial products, processes, or services. The views and opinions expressed within NHMRC case studies are not necessarily those of the Australian Government. The case studies are not to be used for advertising or product endorsement purposes.